PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neurobiology of Disease

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.NBD.2007.07.010PMID 17707122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PINK1 protein in normal human brain and Parkinson's disease.

  2006cited by this paper
• The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity.

  2006cited by this paper
• Polyglutamine-expanded ataxin-7 activates mitochondrial apoptotic pathway of cerebellar neurons by upregulating Bax and downregulating Bcl-x(L).

  2006cited by this paper
• Parkin affects mitochondrial function and apoptosis in neuronal and myogenic cells.

  2006cited by this paper
• Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL.

  2006cited by this paper
• Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin

  2006cited by this paper
• A heterozygous effect for PINK1 mutations in Parkinson's disease?

  2006cited by this paper
• Expanding insights of mitochondrial dysfunction in Parkinson's disease

  2006cited by this paper
• C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.

  2006cited by this paper
• Localization of LRRK2 to membranous and vesicular structures in mammalian brain

  2006cited by this paper
• Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.

  2006cited by this paper
• Parkin enhances mitochondrial biogenesis in proliferating cells.

  2006cited by this paper
• Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin

  2006cited by this paper
• The permeability transition pore complex in cancer cell death

  2006cited by this paper
• Phosphorylation of rat brain mitochondrial voltage‐dependent anion as a potential tool to control leakage of cytochrome c

  2006cited by this paper
• Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.

  2005cited by this paper
• How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease

  2005cited by this paper
• Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.

  2005cited by this paper
• Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.

  2005cited by this paper
• Molecular pathophysiology of Parkinson's disease.

  2005cited by this paper
• Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.

  2005cited by this paper
• Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis.

  2005cited by this paper
• Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability.

  2005cited by this paper
• Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death.

  2005cited by this paper
• Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes

  2005cited by this paper
• Molecular pathogenesis of Parkinson's disease.

  2005cited by this paper
• Molecular pathogenesis of Parkinson's disease.

  2005cited by this paper
• Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes

  2005cited by this paper
• Cytochrome c release from rat brain mitochondria is proportional to the mitochondrial functional deficit: implications for apoptosis and neurodegenerative disease

  2005cited by this paper
• Wild-type PINK1 Prevents Basal and Induced Neuronal Apoptosis, a Protective Effect Abrogated by Parkinson Disease-related Mutations*

  2005cited by this paper
• Heterodimerization of opioid receptor‐like 1 and µ‐opioid receptors impairs the potency of µ receptor agonist

  2005cited by this paper
• Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice*

  2004cited by this paper
• Mitochondria and dopamine: new insights into recessive parkinsonism.

  2004cited by this paper
• Control of mitochondrial permeability by Bcl-2 family members.

  2004cited by this paper
• Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells

  2004cited by this paper
• Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism

  2004cited by this paper
• Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

  2004cited by this paper
• Novel PINK1 mutations in early‐onset parkinsonism

  2004cited by this paper
• PINK1 mutations are associated with sporadic early‐onset parkinsonism

  2004cited by this paper
• Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease.

  2004cited by this paper
• DJ‐1 has a role in antioxidative stress to prevent cell death

  2004cited by this paper
• Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

  2004cited by this paper
• The Pathophysiology of Mitochondrial Cell Death

  2004cited by this paper
• The pesticide rotenone induces caspase‐3‐mediated apoptosis in ventral mesencephalic dopaminergic neurons

  2003cited by this paper
• Neurological diseases: Targeting programmed cell death in neurodegenerative diseases

  2003cited by this paper
• Mechanism of Toxicity in Rotenone Models of Parkinson's Disease

  2003cited by this paper
• Protein Kinase C&egr; Interacts With and Inhibits the Permeability Transition Pore in Cardiac Mitochondria

  2003cited by this paper
• Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

  2002cited by this paper
• Mitochondrial permeability transition as a novel principle of hepatorenal toxicity in vivo

  2002cited by this paper
• Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of mu-opioid receptors.

  2002cited by this paper
• Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway

  2001influential reference
• Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

  2001cited by this paper
• Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36.

  2001cited by this paper
• Proteasome Inhibitors Induce Cytochrome c–Caspase-3-Like Protease-Mediated Apoptosis in Cultured Cortical Neurons

  2000cited by this paper
• Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator

  2000cited by this paper
• Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

  2000cited by this paper
• Apoptosis in neural development and disease.

  2000cited by this paper
• Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC

  1999cited by this paper
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper

• The Mitochondrial Connection in Parkinson's Disease.

  2025cites this paper
• A heterozygous variation of PINK1 is potentially associated with essential tremor in a Chinese family

  2025cites this paper
• Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery

  2025cites this paper
• p17/C18-ceramide–mediated mitophagy is an endogenous neuroprotective response in preclinical and clinical brain injury

  2024cites this paper
• Exploring the molecular mechanism of Parkinson's disease triggered by combined atrazine and simazine exposure

  2024cites this paper
• Involvement of Mitochondria in Parkinson’s Disease

  2023cites this paper
• Japanese Encephalitis Virus NS4A Protein Interacts with PTEN-Induced Kinase 1 (PINK1) and Promotes Mitophagy in Infected Cells

  2022cites this paper
• Systematic analysis of PINK1 variants of unknown significance shows intact mitophagy function for most variants

  2021cites this paper
• Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson’s Disease

  2021cites this paper
• Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson’s Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line

  2020cites this paper
• Understanding the pathogenesis involved in Parkinson's disease and potential therapeutic treatment strategies.

  2020cites this paper
• Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases

  2020cites this paper
• PINK1 Interacts with VCP/p97 and Activates PKA to Promote NSFL1C/p47 Phosphorylation and Dendritic Arborization in Neurons

  2018cites this paper
• The Interplay among PINK1/PARKIN/Dj-1 Network during Mitochondrial Quality Control in Cancer Biology: Protein Interaction Analysis

  2018cites this paper
• Apoptosis and its Role in Parkinson’s Disease

  2018cites this paper
• Methylmercury and Paraquat Induced Toxicity in the Mitochondria of Dopamine Neurons

  2017cites this paper
• PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease

  2017cites this paper
• Understanding the mechanism of oxidative stress generation by oxidized dopamine metabolites: Implications in Parkinson's disease

  2017influential citation
• Perturbed Brain Energy Metabolism in Alzheimer’s Disease and Diabetes

  2017cites this paper
• PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway

  2017cites this paper
• Gene therapy targeting mitochondrial pathway in Parkinson’s disease

  2017cites this paper
• Mitochondrial control of cell bioenergetics in Parkinson's disease.

  2016cites this paper
• Mitochondrial dysfunction in Parkinson's disease

  2016cites this paper
• The Parkinson Disease Mitochondrial Hypothesis

  2016cites this paper
• Mechanisms Implicated in Parkinson Disease from Genetic Perspective

  2016cites this paper
• New insights on the mitochondrial proteome plasticity in Parkinson's disease

  2016cites this paper
• Energy metabolism and Protein synthesis in Parkinson's disease and Dementia with Lewy Bodies

  2015cites this paper
• Molecular characterization of the Parkinson's associated protein DJ-1

  2015cites this paper
• Functions and characteristics of PINK1 and Parkin in cancer.

  2015cites this paper
• Molecular Targets for Improvement of Parkinson’s Disease Therapy

  2015cites this paper
• The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology.

  2015cites this paper
• Molecular Targets for Improvement of Parkinson's Disease Therapy

  2015cites this paper
• Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism

  2014cites this paper
• Inhibition Functions and characteristics of PINK 1 and Parkin in cancer

  2014cites this paper
• PINK1 and Its Familial Parkinson's Disease-Associated Mutation Regulate Brain Vascular Endothelial Inflammation

  2014cites this paper
• Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.

  2014cites this paper
• The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes

  2014cites this paper
• Mitochondria: prospective targets for neuroprotection in Parkinson's disease.

  2014cites this paper
• The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease

  2014cites this paper
• Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through Protein Kinase A

  2014cites this paper
• Loss of PINK 1 Increases the Heart ’ s Vulnerability to Ischemia-Reperfusion Injury

  2013cites this paper
• PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates.

  2013cites this paper
• Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map

  2013cites this paper
• Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury

  2013cites this paper
• Function and Characteristics of PINK1 in Mitochondria

  2013cites this paper
• Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.

  2013cites this paper
• A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.

  2013influential citation
• dendrites through Protein Kinase A

  2013cites this paper
• Mitochondrial diseases of the brain.

  2013cites this paper
• Mitochondrial dysfunction and oxidative stress in Parkinson's disease.

  2013cites this paper
• Increase of oxidative stress by a novel PINK1 mutation, P209A.

  2013cites this paper
• Therapeutic potential of targeting group III metabotropic glutamate receptors as a disease modifying strategy in the treatment of Parkinson's disease

  2012cites this paper
• Regulation of mitochondrial fates and cellular metabolism via parkin-mediated mitophagy and interaction between apoptosis and autophagy pathways in cancer

  2012cites this paper
• Expression of Pink1 with α-synuclein in the dopaminergic neurons of Drosophila leads to increases in both lifespan and healthspan.

  2012cites this paper
• Programmed cell death in Parkinson's disease.

  2012cites this paper
• Mitochondrial biology and Parkinson's disease.

  2012cites this paper
• PINK1 Overexpression Protects Against C2-ceramide-Induced CAD Cell Death Through the PI3K/AKT Pathway

  2012cites this paper
• Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond

  2012cites this paper
• Loss of PINK1 function decreases PP2A activity and promotes autophagy in dopaminergic cells and a murine model.

  2011cites this paper
• PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons.

  2011influential citation
• PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells.

  2011cites this paper
• Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease

  2011cites this paper
• Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis.

  2011cites this paper
• Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update

  2010influential citation
• Control of mitochondrial integrity in Parkinson's disease.

  2010cites this paper
• The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy

  2010cites this paper
• Unlocking the Door to Neuronal Woes in Alzheimer’s Disease: Aβ and Mitochondrial Permeability Transition Pore

  2010cites this paper
• Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy.

  2010cites this paper
• Generation and analysis of a Pink1 deficient mouse model for Parkinson's disease

  2010cites this paper
• Signal transduction to the permeability transition pore

  2010cites this paper
• Mechanism of action of autosomal recessive juvenile parkinsonism gene mutations

  2010cites this paper
• Mitochondrial medicine for neurodegenerative diseases.

  2010cites this paper
• Tickled PINK1: mitochondrial homeostasis and autophagy in recessive Parkinsonism.

  2010cites this paper
• Neurochemistry changes associated with mutations in familial Parkinson's disease.

  2010cites this paper
• Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission*

  2009cites this paper
• Regulation of PINK1 by NR2B‐containing NMDA receptors in ischemic neuronal injury

  2009cites this paper
• The role of PTEN in cardioprotection against ischaemia-reperfusion injury

  2009cites this paper
• Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

  2009cites this paper
• Mitochondrial respiratory dysfunction and mutations in mitochondrial DNA in PINK1 familial Parkinsonism

  2009cites this paper
• A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.

  2009cites this paper
• The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics.

  2009cites this paper
• Cell Death Pathways in Parkinson's Disease: Role of Mitochondria

  2009cites this paper
• Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease.

  2009cites this paper
• The mitochondrial kinase PINK1, stress response and Parkinson’s disease

  2009cites this paper
• Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.

  2009cites this paper
• Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells

  2009cites this paper
• Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle

  2009cites this paper
• Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

  2009cites this paper
• Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease.

  2008cites this paper
• Mitochondrial alterations in Parkinson’s disease: new clues

  2008cites this paper
• Mitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation

  2008cites this paper
• Correction: PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons

  2008cites this paper
• PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons

  2008cites this paper
• On the pathogenesis and neuroprotective treatment of Parkinson disease: what have we learned from the genetic forms of this disease?

  2008cites this paper
• Functional Genomics Studies of PINK1

  2007cites this paper
• NHANCED VULNERABILITY OF PARK 6 PATIENT SKIN IBROBLASTS TO APOPTOSIS INDUCED BY PROTEASOMAL STRESS

  year unknowncites this paper